MARIA DOLORES FRUTOS BERNAL

Nunez-Sanchez MA, Martinez-Sanchez MA, Martinez-Montoro JI, Balaguer-Roman A, Murcia-Garcia E, Fernandez-Ruiz VE, Ferrer-Gomez M, Martinez-Caceres CM, Sledzinski T, Frutos MD, Hernandez-Morante JJ, Fernandez-Garcia JC, Queipo-Ortuno MI, Ruiz-Alcaraz AJ, Mika A, Ramos-Molina B. Lipidomic analysis reveals alterations in hepatic FA profile associated with MASLD stage in patients with obesity. J Clin Endocrinol Metab. 2024 Jan 13:dgae028. doi: 10.1210/clinem/dgae028. Online ahead of print. PubMed PMID: 38217869.

AÑO: 2024; IF: 5.8

38217869

Castellano-Castillo D, Nunez-Sanchez MA, Balaguer-Roman A, Martinez-Sanchez MA, Fernandez-Ruiz VE, Ferrer-Gomez M, Martinez CM, Frutos MD, Queipo-Ortuno MI, Cardona F, Ramos-Molina B. The role of PCSK9 in metabolic dysfunction-associated steatotic liver disease and its impact on bariatric surgery outcomes. Surg Obes Relat Dis. 2024 Feb 6:S1550-7289(24)00042-X. doi: 10.1016/j.soard.2024.01.017. Online ahead of print. PubMed PMID: 38490825.

AÑO: 2024; IF: 3.1

38490825

Castellano-Castillo D, Ramos-Molina B, Frutos MD, Arranz-Salas I, Reyes-Engel A, Queipo-Ortuno MI, Cardona F. RNA expression changes driven by altered epigenetics status related to NASH etiology. Biomed Pharmacother. 2024 Apr 4;174:116508. doi: 10.1016/j.biopha.2024.116508. Online ahead of print. PubMed PMID: 38579398.

AÑO: 2024; IF: 7.5

38579398

Martinez-Montoro JI, Nunez-Sanchez MA, Martinez-Sanchez MA, Balaguer-Roman A, Fernandez-Ruiz VE, Ferrer-Gomez M, Sledzinski T, Frutos MD, Fernandez-Garcia JC, Mika A, Ramos-Molina B. Hepatic and serum branched-chain fatty acid profile in patients with nonalcoholic fatty liver disease: A case-control study. Obesity (Silver Spring). 2023 Mar 6. doi: 10.1002/oby.23711. Online ahead of print. PubMed PMID: 36876627.

AÑO: 2023; IF: 6.9

36876627

Babiy B, Ramos-Molina B, Ocana L, Sacristan S, Burgos-Santamaria D, Martinez-Botas J, Busto R, Perna C, Frutos MD, Albillos A, Pastor O. Dihydrosphingolipids are associated with steatosis and increased fibrosis damage in non-alcoholic fatty liver disease. Biochim Biophys Acta Mol Cell Biol Lipids. 2023 Apr 12:159318. doi: 10.1016/j.bbalip.2023.159318. Online ahead of print. PubMed PMID: 37059386.

AÑO: 2023; IF: 4.8

37059386